CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRVO CervoMed

休市中 09-11 16:00:00 EDT

2.57

+0.09

+3.63%

盘后2.63

+0.06+2.33%

19:30 EDT

最高2.64	最低2.50	成交量23.46万
今开2.54	昨收2.48	日振幅5.63%
总市值3,886万	流通市值2,468万	总股本1,512万
成交额60.11万	换手率2.44%	流通股本960.44万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":2.57,"timestamp":1789156800000,"preClose":2.48,"halted":0,"volume":234572,"hourTrading":{"tag":"盘后","latestPrice":2.63,"preClose":2.57,"latestTime":"19:30 EDT","volume":1312,"amount":3417.6245,"timestamp":1789169405347,"change":0.06,"changeRate":0.023346,"amplitude":0.027237},"delay":0,"changeRate":0.0362903225806451,"floatShares":9604400,"shares":15119100,"eps":-3.195903,"marketStatus":"休市中","change":0.09,"latestTime":"09-11 16:00:00 EDT","open":2.54,"high":2.6396,"low":2.5,"amount":601108.3428999999,"amplitude":0.05629,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.195903,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.48,"preHourTrading":{"tag":"盘前","latestPrice":2.52,"preClose":2.48,"latestTime":"09:27 EDT","volume":3001,"amount":7471.162057500001,"timestamp":1789133246903,"change":0.04,"changeRate":0.016129,"amplitude":0.052419},"postHourTrading":{"tag":"盘后","latestPrice":2.63,"preClose":2.57,"latestTime":"19:30 EDT","volume":1312,"amount":3417.6245,"timestamp":1789169405347,"change":0.06,"changeRate":0.023346,"amplitude":0.027237},"volumeRatio":1.2060877158479586},"requestUrl":"/m/hq/s/CRVO","defaultTab":"news","newsList":[{"id":"1104486898","title":"CervoMed宣布Neflamapimod治疗非流利变异型原发性进行性失语（nfvPPA）的2a期临床试验初步结果入选ISFTD 2026最新突破口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1104486898","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104486898?lang=zh_cn&edition=full","pubTime":"2026-09-10 19:32","pubTimestamp":1789039923,"startTime":"0","endTime":"0","summary":"CervoMed今日宣布，其评估Neflamapimod用于非流利变异型原发性进行性失语治疗的2a期临床试验初步结果，已被2026年国际额颞叶痴呆大会接受为最新突破口头报告。ISFTD作为全球聚焦额颞叶痴呆及其相关疾病的前沿学术平台，其遴选标准极为严苛，能够在众多投稿中获得口头报告席位，本身就印证了该研究成果的科学价值与临床意义。市场分析人士指出，这一进展有望为CervoMed在神经科学管线上的估值带来积极催化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144170029","title":"CervoMed 在 AAIC 2026 公布 Neflamapimod 治疗路易体痴呆的新临床、血浆生物标志物及影像学数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1144170029","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144170029?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:32","pubTimestamp":1784028776,"startTime":"0","endTime":"0","summary":"CervoMed 在 2026 年阿尔茨海默病协会国际会议上，公布了其药物 Neflamapimod 用于治疗路易体痴呆的最新研究成果。此次公布的数据涵盖了关键的临床疗效指标、创新的血浆生物标志物分析以及先进的神经影像学发现，为评估该疗法的潜力提供了多维度的证据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170264182","title":"CervoMed宣布完成Neflamapimod针对非流利变异型原发性进行性失语症（一种额颞叶痴呆）的二期研究入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1170264182","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170264182?lang=zh_cn&edition=full","pubTime":"2026-07-09 19:32","pubTimestamp":1783596724,"startTime":"0","endTime":"0","summary":"CervoMed已宣布，其药物Neflamapimod针对非流利变异型原发性进行性失语症（一种额颞叶痴呆）的第二阶段临床试验，现已成功完成患者入组工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132605708","title":"CervoMed完成1000万美元纳斯达克规则下普通股注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1132605708","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132605708?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:05","pubTimestamp":1782158721,"startTime":"0","endTime":"0","summary":"CervoMed宣布，其已根据纳斯达克市场规则，完成一笔定价为市场价格的普通股注册直接发行，募集资金总额达1000万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146627967","title":"CervoMed宣布根据纳斯达克规则进行1000万美元普通股市场价注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1146627967","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146627967?lang=zh_cn&edition=full","pubTime":"2026-06-19 00:36","pubTimestamp":1781800571,"startTime":"0","endTime":"0","summary":"CervoMed宣布，将根据纳斯达克规则进行一项价值1000万美元的普通股注册直接发行，发行价格将按市场价确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121123878","title":"CervoMed宣布私募融资计划 将聚焦战略合作以推进Neflamapimod进入路易体痴呆症三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=1121123878","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121123878?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:30","pubTimestamp":1781091016,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布了一项私募融资计划，并披露了其未来战略重心：公司将致力于寻求战略合作伙伴，以推动其核心候选药物Neflamapimod进入针对路易体痴呆症的第三阶段临床试验。这一举措旨在为关键性临床研究获取必要资源，加速该疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176804788","title":"CervoMed计划于2026年下半年启动Neflamapimod针对DLB患者的III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1176804788","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176804788?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:36","pubTimestamp":1779104183,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，计划在2026年下半年启动一项III期临床试验，旨在评估其候选药物Neflamapimod在路易体痴呆（DLB）患者中的疗效与安全性。这一举措标志着该药物研发进程中的重要一步，公司正积极推进其针对神经退行性疾病的治疗管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163917918","title":"CervoMed将于2026年路易体痴呆协会年会公布Neflamapimod临床项目进展并参与生物标志物专题讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=1163917918","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163917918?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:31","pubTimestamp":1775561473,"startTime":"0","endTime":"0","summary":"CervoMed宣布，公司计划在2026年路易体痴呆协会年度会议上，详细介绍其核心候选药物Neflamapimod的临床研发项目最新数据与进展。此外，CervoMed的研究专家还将受邀参与一场关于生物标志物的专题小组讨论，分享在该领域的见解与发现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190106082","title":"CervoMed于2026年Ad/Pd™科学会议公布新数据，进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190106082","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190106082?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:33","pubTimestamp":1773920016,"startTime":"0","endTime":"0","summary":"CervoMed在2026年Ad/Pd™科学会议上公布了最新研究数据，这些数据强化了Neflamapimod药物对不伴有阿尔茨海默病共病理的路易体痴呆患者的治疗效果。新发现突显该疗法在特定患者群体中的显著优势，为精准医疗提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169419","title":"Cervomed Inc.盘中异动 早盘快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512169419?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:05","pubTimestamp":1739891114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时05分，Cervomed Inc.股票出现异动，股价大幅下跌5.15%。截至发稿，该股报2.21美元/股，成交量2.9744万股，换手率0.36%，振幅5.58%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为333.39%、127.78%、119.54%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.，振幅分别为41.79%、34.04%、33.58%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230514a24ab453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230514a24ab453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510360043","title":"Cervomed Inc.盘中异动 急速下跌5.02%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510360043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510360043?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:45","pubTimestamp":1739288742,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时45分，Cervomed Inc.股票出现异动，股价急速下挫5.02%。截至发稿，该股报2.08美元/股，成交量2.9468万股，换手率0.36%，振幅4.80%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为1.85%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2719.51%、1098.32%、377.13%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234542a2420bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234542a2420bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045519","title":"Cervomed Inc.盘中异动 临近午盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505045519?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:40","pubTimestamp":1737650405,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时40分，Cervomed Inc.股票出现波动，股价大幅拉升5.50%。截至发稿，该股报2.30美元/股，成交量3.3895万股，换手率0.41%，振幅6.88%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3599.77%、2463.29%、660.66%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为246.43%、64.29%、55.57%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240040059870d354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240040059870d354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505392781","title":"Cervomed Inc.盘中异动 临近收盘快速上涨5.21%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505392781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505392781?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:33","pubTimestamp":1737491581,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时33分，Cervomed Inc.股票出现波动，股价大幅上涨5.21%。截至发稿，该股报2.22美元/股，成交量6.6461万股，换手率0.81%，振幅5.92%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为1.85%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1615.85%、528.30%、191.03%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、67.67%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043301960bf5dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043301960bf5dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502145703","title":"Cervomed Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502145703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502145703?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:28","pubTimestamp":1736357332,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时28分，Cervomed Inc.股票出现异动，股价快速跳水5.16%。截至发稿，该股报2.19美元/股，成交量8.3998万股，换手率1.02%，振幅4.56%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3430.46%、595.63%、588.02%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012852985f965a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012852985f965a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501901259","title":"Cervomed Inc.盘中异动 股价大跌5.03%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501901259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501901259?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:34","pubTimestamp":1736177699,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时34分，Cervomed Inc.股票出现波动，股价快速下跌5.03%。截至发稿，该股报2.21美元/股，成交量8.0961万股，换手率0.98%，振幅3.83%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1166.43%、306.55%、99.39%，振幅较大的相关个股有Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为176.15%、71.31%、54.46%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233459985cf371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233459985cf371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500114209","title":"Cervomed Inc.盘中异动 早盘大幅拉升5.83%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500114209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500114209?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:41","pubTimestamp":1735915295,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时41分，Cervomed Inc.股票出现波动，股价急速拉升5.83%。截至发稿，该股报2.36美元/股，成交量7720股，换手率0.09%，振幅4.48%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为971.62%、752.32%、268.94%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为121.56%、75.47%、48.07%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224135985a3f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224135985a3f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495717615","title":"Cervomed Inc.盘中异动 早盘快速跳水5.69%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495717615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495717615?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:30","pubTimestamp":1735655452,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时30分，Cervomed Inc.股票出现异动，股价快速下跌5.69%。截至发稿，该股报2.25美元/股，成交量3935股，换手率0.05%，振幅0.00%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为849.65%、617.36%、130.44%，振幅较大的相关个股有Eyenovia, Inc.、Onconetix, Inc.、Portage Biotech Inc.，振幅分别为18.27%、11.44%、10.12%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493664807","title":"Cervomed Inc.盘中异动 早盘股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493664807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493664807?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:37","pubTimestamp":1734964647,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时37分，Cervomed Inc.股票出现波动，股价快速上涨5.35%。截至发稿，该股报2.35美元/股，成交量3.8195万股，换手率0.46%，振幅2.69%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为679.69%、459.33%、313.86%，振幅较大的相关个股有Gt Biopharma, Inc.、Rapt Therapeutics, Inc.、Traws Pharma, Inc.，振幅分别为43.97%、41.19%、39.04%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223728a2050c74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223728a2050c74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492440538","title":"Cervomed Inc.盘中异动 急速跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492440538?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:14","pubTimestamp":1734707657,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时14分，Cervomed Inc.股票出现异动，股价急速下跌5.83%。截至发稿，该股报2.10美元/股，成交量9.2782万股，换手率1.12%，振幅3.59%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为2167.58%、102.62%、57.52%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Humacyte, Inc.，振幅分别为84.80%、50.00%、48.53%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220231418a1fe3a87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220231418a1fe3a87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492513376","title":"Cervomed Inc.盘中异动 早盘股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492513376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492513376?lang=zh_cn&edition=full","pubTime":"2024-12-19 00:27","pubTimestamp":1734539270,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日00时27分，Cervomed Inc.股票出现异动，股价大幅拉升5.67%。截至发稿，该股报2.05美元/股，成交量12.3912万股，换手率1.50%，振幅7.73%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2709.74%、549.46%、308.77%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、118.27%、66.83%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219002751ab823996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219002751ab823996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cervomed.com","stockEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":-0.1629},{"period":"3month","weight":0.049},{"period":"6month","weight":-0.3953},{"period":"1year","weight":-0.7207},{"period":"ytd","weight":-0.6747}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CervoMed Inc.最初于1995年1月10日根据内华达州法律注册成立，并于2015年6月18日在特拉华州重新注册成立。该公司是一家临床阶段的生物技术公司，专注于开发与年龄相关的神经系统疾病的治疗方法。他们的主要候选药物neflamapimod是一种在研的口服小分子药物，能够轻松穿过血脑屏障，并选择性地抑制p38α酶——一种神经炎症和突触功能障碍的关键驱动因素。通过靶向脑部退行性疾病的关键病理过程，neflamapimod有望逆转突触功能障碍，改善神经元健康，并延缓或阻止疾病进展。Neflamapimod目前正处于治疗路易体痴呆 (DLB)（其主要适应症）以及非流利型原发性进行性失语症 (nfvPPA)、类风湿性关节炎 (RAS) 和肌萎缩侧索硬化症 (ALS) 的临床开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.023389},{"month":2,"riseRate":0.5,"avgChangeRate":0.085839},{"month":3,"riseRate":0.5,"avgChangeRate":0.326048},{"month":4,"riseRate":0.3,"avgChangeRate":-0.063988},{"month":5,"riseRate":0.4,"avgChangeRate":0.116259},{"month":6,"riseRate":0.1,"avgChangeRate":-0.109707},{"month":7,"riseRate":0.2,"avgChangeRate":-0.086929},{"month":8,"riseRate":0.7,"avgChangeRate":0.070615},{"month":9,"riseRate":0.1,"avgChangeRate":-0.108214},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.039339},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.045938},{"month":12,"riseRate":0.3,"avgChangeRate":-0.206034}],"exchange":"NASDAQ","name":"CervoMed","nameEN":"CervoMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CervoMed,CRVO,CervoMed股票,CervoMed股票老虎,CervoMed股票老虎国际,CervoMed行情,CervoMed股票行情,CervoMed股价,CervoMed股市,CervoMed股票价格,CervoMed股票交易,CervoMed股票购买,CervoMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}